Curis, Inc.
NASDAQ:CRIS
Overview | Financials
Company Name | Curis, Inc. |
Symbol | CRIS |
Currency | USD |
Price | 3.46 |
Market Cap | 29,295,682 |
Dividend Yield | 0% |
52-week-range | 2.86 - 17.49 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. James E. Dentzer |
Website | https://www.curis.com |
An error occurred while fetching data.
About Curis, Inc.
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD